In vivo trafficking and targeting of N-cadherin to nascent presynaptic terminals

被引:65
|
作者
Jontes, JD [1 ]
Emond, MR [1 ]
Smith, SJ [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA
来源
JOURNAL OF NEUROSCIENCE | 2004年 / 24卷 / 41期
关键词
adhesion; imaging; spinal; synaptogenesis; Rohon-Beard; in vivo;
D O I
10.1523/JNEUROSCI.5399-04.2004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
N-cadherin is a prominent component of developing and mature synapses, yet very little is known about its trafficking within neurons. To investigate N-cadherin dynamics in developing axons, we used in vivo two-photon time-lapse microscopy of N-cadherin - green fluorescent protein (Ncad - GFP), which was expressed in Rohon - Beard neurons of the embryonic zebrafish spinal cord. Ncad - GFP was present as either stable accumulations or highly mobile transport packets. The mobile transport packets were of two types: tubulovesicular structures that moved preferentially in the anterograde direction and discrete - punctate structures that exhibited bidirectional movement. Stable puncta of Ncad - GFP accumulated in the wake of the growth cone with a time course. Colocalization of Ncad - GFP puncta with synaptic markers suggests that N-cadherin is a very early component of nascent synapses. Expression of deletion mutants revealed a potential role of the extracellular domain in appropriate N-cadherin trafficking and targeting. These results are the first to characterize the trafficking of a synaptic cell-adhesion molecule in developing axons in vivo. In addition, we have begun to investigate the cell biology of N-cadherin trafficking and targeting in the context of an intact vertebrate embryo.
引用
收藏
页码:9027 / 9034
页数:8
相关论文
共 50 条
  • [31] Effects of N-cadherin on APP homodimerization
    Asada, Megumi
    Uemura, Kengo
    Kuzuya, Akira
    Kubota, Masakazu
    Shimohama, Shun
    Takahashi, Ryosuke
    Kinoshita, Ayae
    NEUROSCIENCE RESEARCH, 2009, 65 : S115 - S115
  • [32] N-cadherin as a therapeutic target in cancer
    Mariotti, Agnese
    Perotti, Antonella
    Sessa, Cristiana
    Rueegg, Curzio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (04) : 451 - 465
  • [33] Aberrant N-cadherin expression in cancer
    Cao, Zhan-Qi
    Wang, Zhi
    Leng, Ping
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [34] N-cadherin enhances extracellular secretion of Aβ
    Uemura, Kengo
    Kuzuya, Akira
    Aoyagi, Nobuhisa
    Ando, Koichi
    Takahashi, Ryosuke
    Shimohama, Shun
    Kinoshita, Ayae
    NEUROSCIENCE RESEARCH, 2007, 58 : S117 - S117
  • [35] Discovery and development of N-cadherin antagonists
    Blaschuk, Orest W.
    CELL AND TISSUE RESEARCH, 2012, 348 (02) : 309 - 313
  • [36] Discovery and development of N-cadherin antagonists
    Orest W. Blaschuk
    Cell and Tissue Research, 2012, 348 : 309 - 313
  • [37] N-cadherin at the glial scar in the rat
    Vázquez-Chona, F
    Geisert, EE
    BRAIN RESEARCH, 1999, 838 (1-2) : 45 - 50
  • [38] Role of N-cadherin in bone formation
    Marie, PJ
    JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 190 (03) : 297 - 305
  • [39] N-cadherin antagonists as oncology therapeutics
    Blaschuk, Orest W.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2015, 370 (1661)
  • [40] Identification of novel N-cadherin antagonist
    Devemy, Emmanuelle
    Blaschuk, Orest W.
    PEPTIDES, 2008, 29 (11) : 1853 - 1861